Antibody-Drug Conjugate Clinical Trials
3 recruitingDrug
Phase 11Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Cancer
MBrace Therapeutics130 enrolled17 locationsNCT06014658
Recruiting
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
Multiple Myeloma (MM)Multiple Myeloma, Relapsed
Sung-Soo Park174 enrolled1 locationNCT07051850
Recruiting
Immunotherapy in Lymphoma
Relapsed/refractory High Grade B Cell Lymphoma
Sung-Soo Park72 enrolled2 locationsNCT06796517